During the past decade, Center For Sight conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 7 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center For Sight" #1 sponsor was "Allergan" with 3 trials, followed by "Johnson & Johnson Surgical Vision, Inc." with 2 trials sponsored, "Aerie Pharmaceuticals" with 1 trials sponsored, "Carolina Eyecare Physicians, LLC" with 1 trials sponsored and "Case Western Reserve University" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center For Sight" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Center For Sight" are "Cataract" (3 trials), "Presbyopia" (3 trials), "Glaucoma, Open-Angle" (2 trials), "Ocular Hypertension" (2 trials) and "Cornea Preservation Time" (1 trials). Many other conditions were trialed in "Center For Sight" in a lesser frequency.

Most popular intervention types in "Center For Sight" are "Device" (7 trials), "Drug" (7 trials), "Other" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "AGN-190584 Vehicle" (1 trials), "AGN-190584 ophthalmic solution" (1 trials), "AGN-199201 Vehicle" (1 trials), "AGN-199201 ophthalmic solution" (1 trials) and "Active Comparator: Timolol 0.5%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center For Sight" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Center For Sight". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Center For Sight, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Center For Sight, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".